Fluctuation of BCR-ABL1 qPCRIS level beyond 0.1%IS after stopping tyrosine kinase inhibitor in chronic myeloid leukaemia patients with deep molecular response for at least two years

• Main Authors: Kuan, Jew-Win, Chang, Kian-Meng, Chin, Lee Phan, Wong, Shu Ping, Lim, Soo Min, Toh, See Guan, Loh, Weng Khean
• Format: Article
• Language: English
• Published: NCBI Literature Resources 2021
• Subjects: R Medicine (General); RD Surgery
• Online Access: http://ir.unimas.my/id/eprint/37246/1/myeloid1.pdf; http://ir.unimas.my/id/eprint/37246/; https://pubmed.ncbi.nlm.nih.gov/34031342/

Fluctuation of BCR-ABL1 real-time quantitative polymerase chain reaction in International Scale (qPCRIS ) level below major molecular response (MMR) (0.1%IS ) is a known phenomenon after stopping tyrosine kinase inhibitor (TKI) in chronic myeloid leukaemia (CML) patients who are attempting tr...